arrow
返回
A

Adam Reich

university of rzeszow

62H指数
639论文数
1.5W被引数
收录论文 230
发表时间
Dermoscopy of Subungual Squamous Cell Carcinoma: A Systematic Review甲下鳞状细胞癌的皮肤镜检查:系统综述
errCancers
IF4.4
err2026-01-30
err0
errOAAI
errEwelina Mazur; Dominika Kwiatkowska; Myrto Trakatelli; Elizavet Lazaridou; Zoe Apalla; Aikaterini Patsatsi; Styliani Siskou; Anastasia Trigoni; Christina Kemanetzi; Adam Reich
err分享
err收藏
err分享
err收藏
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b StudyAmlitelimab STREAM-AD 二期研究的头颈部特应性皮炎与其他身体部位特应性皮炎的事后分析
err2025-12-08
err0
errOAAI
errAdam Reich; Andrew Blauvelt; Stephan Weidinger; Vivian Y. Shi; Norito Katoh; Charles Lynde; Xinghua Gao; Nicole M. Armstrong; Charlotte Bernigaud; Kassim Rahawi
err分享
err收藏
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous Urticaria慢性自发性荨麻疹患者中Ligelizumab作为再治疗的长效疗效与安全性
err2025-12-08
err0
errOAAI
errAna M. Gimenez-Arnau; Marcus Maurer; Adam Reich; Chia-Yu Chu; Diana Deleanu; Gordon Sussman; Jorge Sanchez; Knut Brockow; Koremasa Hayama; Michihiro Hide; Mohamed Denguezli; Raisa Meshkova; Roberta F. J. Criado; Sarbjit Saini; Solange Valle; Eva Hua; Pengpeng Wang; Alis Burciu; Isabelle Indermuehle; Vineeth Varanasi; Yolandi Joubert; Thomas Severin; Manmath Patekar
err分享
err收藏
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis奈莫珠单抗治疗结节性痒疹长达100周: 奥林匹亚LTE中期分析
err2025-12-01
err0
errOAAI
errLegat, Franz J.; Kwatra, Shawn G.; Reich, Adam; Boulinguez, Serge; Tsianakas, Athanasios; Sauder, Maxwell; Barbarot, Sebastien; Szepietowski, Jacek C.; Conrad, Curdin; Pink, Andrew E.; Weisshaar, Elke; Misery, Laurent; Metz, Martin; Laquer, Vivian T.; Sivamani, Raja K.; Yosipovitch, Gil; Thaci, Diamant; Skov, Lone; Chen, Xiaoxiao; Noda, Aliene; Jabbar-Lopez, Zarif K.; Piketty, Christophe; Stander, Sonja
err分享
err收藏
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals慢性累积性生命历程损伤是否被纳入银屑病管理?——一项针对银屑病患者和医疗保健专业人士的多国调查
err2025-11-22
err0
errOAAI
errRaymond Matthews; April W. Armstrong; Matthias Augustin; Christopher Baker; José Manuel Carrascosa; Brian Kirby; Richard Langley; Sandy McBride; Adam Reich; Ricardo Romiti; Francesca Sampogna; Richard B. Warren
err分享
err收藏
Targeting IL-22RA1 with Temtokibart: A Novel Approach in Atopic Dermatitis: Phase 2a Monotherapy Study Results靶向IL-22RA1的Temtokibart:特应性皮炎的一种新方法:2a期单药治疗研究结果
err2025-11-11
err0
errOAAI
errDiamant Thaçi; Vivian Laquer; Charles Lynde; Adam Reich; Weily Soong; Margitta Worm; Petra Arlert; Allan Blemings; Thomas Litman; Britta C. Martel; Martin Olesen; Ole E. Sørensen; Melinda Gooderham
err分享
err收藏
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigoSWITCH算法:针对慢性瘙痒性湿疹的达标治疗标准的专家共识
err2025-11-08
err0
errOAAI
errLea S. Stahl; Claudia Zeidler; Joyce Loewenthal; Svenja Royeck; Matthias Augustin; Robert Bissonnette; Sarina Elmariah; Brian S. Kim; Laurent Misery; Hiroyuki Murota; Hong Liang Tey; Elke Weisshaar; Gil Yosipovitch; Franz J. Legat; Adam Reich; Martin Metz; Sonja Ständer
err分享
err收藏
REZPEGALDESLEUKIN, NOVEL TREG-INDUCING THERAPY, DEMONSTRATES EFFICACY IN ATOPIC DERMATITIS AND ASTHMA IN PHASE 2B TRIALREZPEGALDESLEUKIN,一种新型Treg诱导疗法,在2b期临床试验中显示出对特应性皮炎和哮喘的有效性。
err2025-11-05
err0
PREAI
errJ. Corren; P. Lio; J. Silverberg; R. Chovatiya; M. Gooderham; T. Bieber; R. Warren; N. Sadick; J. Treat; S. Gkalpakiotis; A. Reich; S. Chaudhry; Z. Lee; M. Hannaway; D. Yu; Y. Liu; C. Fanton; M. Zhang; W. Waltz; J. Gilbert; S. Charoenthongtrakul; C. Jue; M. Marcondes; B. Kotzin; M. Tagliaferri; J. Zalevsky; D. Rosmarin
err分享
err收藏
Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial比较生物类似药Bmab 1200与参考药ustekinumab治疗中重度斑块状银屑病的疗效和安全性:来自III期STELLAR-2试验52周的研究结果
err2025-10-21
err0
errOAAI
errJacek C. Szepietowski; Adam Reich; Steven R. Feldman; Grazyna Pulka; Lally Mekokishvili; Nino Tsiskarishvili; Inese Svarca; Airi Poder; Gursharan Singh; Sarika Deodhar; Kuldeep Kumar; Ashwani Marwah; Subramanian Loganathan; Elena Wolff-Holz; Sandeep N. Athalye
err分享
err收藏
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study纳莫利zumab治疗特应性皮炎长达2年的开放标签扩展研究的安全性与有效性
err2025-10-13
err0
errOAAI
errMatthias Augustin; Marie Tauber; Robert Sidbury; Jonathan I. Silverberg; Kim A. Papp; Diamant Thaçi; Marjolein S. De Bruin-Weller; Adam Reich; Ketty Peris; Kirk Barber; Ryszard Galus; Andrzej Kaszuba; Matthew Zirwas; Walter K. Nahm; Gretel Trullenque; Laura Maintz; Sady Alpizar; Sang Wook Son; Vivian Laquer; Linda Stein Gold; Soo Yeon Cheong; Anna Ryzhkova; Agnes Drahos; Liliana Ulianov; Christophe Piketty
err分享
err收藏
Sexual Health in Patients with Atopic Dermatitis: A Cross-Sectional Study特应性皮炎患者的性健康:一项横断面研究
err2025-10-02
err0
errOAAI
errJusko, Natalia; Masajada, Magdalena; Zabowka, Anna; Cmiel, Adam; Brzewski, Pawel; Reich, Adam
err分享
err收藏
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study阿利替利单抗(Amlitelimab),一种抗OX40配体抗体,用于治疗特应性皮炎:STREAM-AD临床研究的简明语言摘要
err2025-09-01
err0
errOAAI
errStephan Weidinger; Andrew Blauvelt; Kim A. Papp; Adam Reich; Chih-Hung Lee; Margitta Worm; Charles Lynde; Yoko Kataoka; Peter Foley; Xiaodan Wei; Wanling Wong; Anne-Catherine Solente; Christine Weber; Samuel Adelman; Sonya Davey; Fabrice Hurbin; Natalie Rynkiewicz; Karl Yen; John T. O’Malley; Charlotte Bernigaud
err分享
err收藏